Riboxin is an anabolic medicine that has antihypoxic and antiarrhythmic effects. It is a precursor of ATP, is directly involved in glucose metabolism and promotes metabolism activation in the conditions of hypoxia and lack of ATP.
Complex treatment of coronary heart disease (condition after myocardial infarction, angina), arrhythmias, cardiac glycoside overdose; treatment of cardiomyopathies of different aetiology, myocardiodystrophies (associated with heavy physical activity, of infectious and endocrine aetiology), myocarditis; liver diseases (hepatitis, hepatic cirrhosis, fatty liver disease); porphyria cutanea tarda.
The medicine should be used in adults orally before meals, not chewed and taken with a sufficient quantity of water. The daily dose is determined by the physician on an individual basis, the dose is 600–2400 mg per day.